Insulet
PODD
$194.54
Share price
2.77%
Change (1 day)
-36.19%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Revenue for Insulet (PODD)
Revenue in 2023 (TTM): $1.55 B
According to Insulet's latest financial reports the company's current revenue (TTM) is $1.55 B. In 2022 the company made a revenue of $1.30 B an increase over the years 2021 revenue that were of $1.09 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Insulet from 2006 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1.55 B | 19.28% |
| 2022 | $1.30 B | 18.79% |
| 2021 | $1.09 B | 21.49% |
| 2020 | $0.90 B | 22.51% |
| 2019 | $0.73 B | 30.93% |
| 2018 | $0.56 B | 21.57% |
| 2017 | $0.46 B | 26.37% |
| 2016 | $0.36 B | 13.19% |
| 2015 | $0.32 B | 12.3% |
| 2014 | $0.28 B | 16.85% |
| 2013 | $0.24 B | 16.9% |
| 2012 | $0.21 B | 38.83% |
| 2011 | $0.15 B | 57.02% |
| 2010 | $96.96 M | 46.85% |
| 2009 | $66.03 M | 83.12% |
| 2008 | $36.05 M | 169.66% |
| 2007 | $13.37 M | 265.06% |
| 2006 | $3.66 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $91.32 B | 5,765.25% | 🇺🇸 USA |
 Abbott Laboratories ABT | $39.95 B | 2,466.41% | 🇺🇸 USA |
 Medtronic MDT | $31.95 B | 1,952.47% | 🇮🇪 Ireland |
 Eli Lilly LLY | $32.07 B | 1,959.89% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.77 B | -50.45% | 🇺🇸 USA |
 ICU Medical
ICUI | $2.24 B | 44.46% | 🇺🇸 USA |
 DexCom DXCM | $3.40 B | 118.56% | 🇺🇸 USA |